# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-18-270464
Filing Date
2018-09-11
Accepted
2018-09-11 08:35:11
Documents
40
Period of Report
2018-09-11
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | d619359d8k.htm | 8-K | 16296
2 | EXHIBIT 99.1 | d619359dex991.htm | EX-99.1 | 37104
3 | GRAPHIC | g619359ex99_1s10g1.jpg | GRAPHIC | 104532
4 | GRAPHIC | g619359ex99_1s11g1.jpg | GRAPHIC | 256422
5 | GRAPHIC | g619359ex99_1s12g1.jpg | GRAPHIC | 226180
6 | GRAPHIC | g619359ex99_1s13g1.jpg | GRAPHIC | 195721
7 | GRAPHIC | g619359ex99_1s14g1.jpg | GRAPHIC | 131277
8 | GRAPHIC | g619359ex99_1s15g1.jpg | GRAPHIC | 190494
9 | GRAPHIC | g619359ex99_1s16g1.jpg | GRAPHIC | 115181
10 | GRAPHIC | g619359ex99_1s17g1.jpg | GRAPHIC | 238920
11 | GRAPHIC | g619359ex99_1s18g1.jpg | GRAPHIC | 167266
12 | GRAPHIC | g619359ex99_1s19g1.jpg | GRAPHIC | 195529
13 | GRAPHIC | g619359ex99_1s1g1.jpg | GRAPHIC | 271607
14 | GRAPHIC | g619359ex99_1s20g1.jpg | GRAPHIC | 158903
15 | GRAPHIC | g619359ex99_1s21g1.jpg | GRAPHIC | 232963
16 | GRAPHIC | g619359ex99_1s22g1.jpg | GRAPHIC | 191566
17 | GRAPHIC | g619359ex99_1s23g1.jpg | GRAPHIC | 151044
18 | GRAPHIC | g619359ex99_1s24g1.jpg | GRAPHIC | 233425
19 | GRAPHIC | g619359ex99_1s25g1.jpg | GRAPHIC | 260742
20 | GRAPHIC | g619359ex99_1s26g1.jpg | GRAPHIC | 153572
21 | GRAPHIC | g619359ex99_1s27g1.jpg | GRAPHIC | 129676
22 | GRAPHIC | g619359ex99_1s28g1.jpg | GRAPHIC | 203631
23 | GRAPHIC | g619359ex99_1s29g1.jpg | GRAPHIC | 200351
24 | GRAPHIC | g619359ex99_1s2g1.jpg | GRAPHIC | 407337
25 | GRAPHIC | g619359ex99_1s30g1.jpg | GRAPHIC | 209378
26 | GRAPHIC | g619359ex99_1s31g1.jpg | GRAPHIC | 184355
27 | GRAPHIC | g619359ex99_1s32g1.jpg | GRAPHIC | 179614
28 | GRAPHIC | g619359ex99_1s33g1.jpg | GRAPHIC | 230945
29 | GRAPHIC | g619359ex99_1s34g1.jpg | GRAPHIC | 99814
30 | GRAPHIC | g619359ex99_1s35g1.jpg | GRAPHIC | 257214
31 | GRAPHIC | g619359ex99_1s36g1.jpg | GRAPHIC | 195784
32 | GRAPHIC | g619359ex99_1s37g1.jpg | GRAPHIC | 194485
33 | GRAPHIC | g619359ex99_1s38g1.jpg | GRAPHIC | 292916
34 | GRAPHIC | g619359ex99_1s3g1.jpg | GRAPHIC | 145914
35 | GRAPHIC | g619359ex99_1s4g1.jpg | GRAPHIC | 243798
36 | GRAPHIC | g619359ex99_1s5g1.jpg | GRAPHIC | 177100
37 | GRAPHIC | g619359ex99_1s6g1.jpg | GRAPHIC | 207514
38 | GRAPHIC | g619359ex99_1s7g1.jpg | GRAPHIC | 187503
39 | GRAPHIC | g619359ex99_1s8g1.jpg | GRAPHIC | 158228
40 | GRAPHIC | g619359ex99_1s9g1.jpg | GRAPHIC | 247747
| Complete submission text file | 0001193125-18-270464.txt |  | 10567314

Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

EIN.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37627 | Film No.: 181064041
SIC: 2834 Pharmaceutical Preparations